BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 18672558)

  • 21. Cancer, immunodeficiency and antiretroviral treatment: results from the Australian HIV Observational Database (AHOD).
    Petoumenos K; van Leuwen MT; Vajdic CM; Woolley I; Chuah J; Templeton DJ; Grulich AE; Law MG;
    HIV Med; 2013 Feb; 14(2):77-84. PubMed ID: 22934689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.
    International Collaboration on HIV and Cancer
    J Natl Cancer Inst; 2000 Nov; 92(22):1823-30. PubMed ID: 11078759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AIDS malignancies in the era of highly active antiretroviral therapy.
    Gates AE; Kaplan LD
    Oncology (Williston Park); 2002 Apr; 16(4):441-51, 456, 459. PubMed ID: 12017534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients.
    Herida M; Mary-Krause M; Kaphan R; Cadranel J; Poizot-Martin I; Rabaud C; Plaisance N; Tissot-Dupont H; Boue F; Lang JM; Costagliola D
    J Clin Oncol; 2003 Sep; 21(18):3447-53. PubMed ID: 12972519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of Northern Italy, 1999-2009.
    Calabresi A; Ferraresi A; Festa A; Scarcella C; Donato F; Vassallo F; Limina R; Castelli F; Quiros-Roldan E;
    HIV Med; 2013 Sep; 14(8):481-90. PubMed ID: 23560682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Change in Pattern of Secondary Cancers After Kaposi Sarcoma in the Era of Antiretroviral Therapy.
    Mukhtar F; Ilozumba M; Utuama O; Cimenler O
    JAMA Oncol; 2018 Jan; 4(1):48-53. PubMed ID: 28837714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: a systematic review.
    Cobucci RN; Lima PH; de Souza PC; Costa VV; Cornetta Mda C; Fernandes JV; Gonçalves AK
    J Infect Public Health; 2015; 8(1):1-10. PubMed ID: 25294086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical epidemiology of Hodgkin lymphoma in HIV-infected patients in the highly active antiretroviral therapy (HAART) era.
    Vilchez RA; Finch CJ; Jorgensen JL; Butel JS
    Medicine (Baltimore); 2003 Mar; 82(2):77-81. PubMed ID: 12640183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study.
    Franceschi S; Lise M; Clifford GM; Rickenbach M; Levi F; Maspoli M; Bouchardy C; Dehler S; Jundt G; Ess S; Bordoni A; Konzelmann I; Frick H; Dal Maso L; Elzi L; Furrer H; Calmy A; Cavassini M; Ledergerber B; Keiser O;
    Br J Cancer; 2010 Jul; 103(3):416-22. PubMed ID: 20588274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
    Gingues S; Gill MJ
    HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Malignancies in HIV-infected patients: descriptive study of 129 cases between 1993 and 2010].
    Meijide H; Mena A; Pernas B; Castro A; López S; Vázquez P; Bello L; Baliñas J; Rodríguez-Martínez G; Pedreira JD
    Rev Chilena Infectol; 2013 Apr; 30(2):156-61. PubMed ID: 23677154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Non Hodgkin's and Hodgkin's lymphomas and HIV: frequency, outcome and immune response under HAART; Clermont-Ferrand University Hospital, 1991-2003].
    Jacomet C; Lesens O; Villemagne B; Darcha C; Tournilhac O; Henquell C; Cormerais L; Gourdon F; Peigue-Lafeuille H; Travade P; Beytout J; Laurichesse H
    Med Mal Infect; 2006 Mar; 36(3):157-62. PubMed ID: 16503104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of non-AIDS-defining malignancies in the HAART era: a clinico-epidemiological study.
    Dauby N; De Wit S; Delforge M; Necsoi VC; Clumeck N
    J Int AIDS Soc; 2011 Mar; 14():16. PubMed ID: 21443771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-AIDS defining cancer (NADC) among HIV-infected patients at an oncology tertiary-care center in Mexico.
    Cornejo-Juárez P; Cavildo-Jerónimo D; Volkow-Fernández P
    AIDS Res Ther; 2018 Oct; 15(1):16. PubMed ID: 30368240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.
    Salzberger B; Hartmann P; Hanses F; Uyanik B; Cornely OA; Wöhrmann A; Fätkenheuer G
    Infection; 2005 Oct; 33(5-6):345-9. PubMed ID: 16258865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of first and second primary cancers diagnosed among people with HIV, 1985-2013: a population-based, registry linkage study.
    Hessol NA; Whittemore H; Vittinghoff E; Hsu LC; Ma D; Scheer S; Schwarcz SK
    Lancet HIV; 2018 Nov; 5(11):e647-e655. PubMed ID: 30245004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer risk in people infected with human immunodeficiency virus in the United States.
    Engels EA; Biggar RJ; Hall HI; Cross H; Crutchfield A; Finch JL; Grigg R; Hylton T; Pawlish KS; McNeel TS; Goedert JJ
    Int J Cancer; 2008 Jul; 123(1):187-94. PubMed ID: 18435450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kaposi's sarcoma in patients with human immunodeficiency virus infection in Taiwan.
    Lin CY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Lo YC; Hung CC; Chang SC
    J Microbiol Immunol Infect; 2009 Jun; 42(3):227-33. PubMed ID: 19812856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.
    Burgi A; Brodine S; Wegner S; Milazzo M; Wallace MR; Spooner K; Blazes DL; Agan BK; Armstrong A; Fraser S; Crum NF
    Cancer; 2005 Oct; 104(7):1505-11. PubMed ID: 16104038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV infection and cancer in the era of highly active antiretroviral therapy (Review).
    Barbaro G; Barbarini G
    Oncol Rep; 2007 May; 17(5):1121-6. PubMed ID: 17390054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.